Intravitreous bevacizumab in the treatment of Macuar edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis)

Transactions of the American Ophthalmological Society

Volumn 106, Issue , 2008, Pages 276-300

  Fish, Gary Edd ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE; ANGIOGENESIS INHIBITOR; GLUCOCORTICOID; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; ARGON LASER; ARTERIOVENOUS ADVENTITIAL SHEATHOTOMY; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECOMPRESSION SURGERY; EYE SURGERY; FEMALE; FOLLOW UP; HEMIRETINAL VEIN OCCLUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA MACULA LUTEA; RISK ASSESSMENT; THICKNESS; TREATMENT OUTCOME; VISION; VISUAL ACUITY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ANTAGONISM; FLUORESCENCE ANGIOGRAPHY; INJECTION; LASER COAGULATION; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 63049130747     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. Bron AJ, Tripathi RC, Tripathi BJ. Wolff's Anatomy of the Eye and Orbit. London: Chapman & Hall; 1997:527.
2. Weinberg DV, Seddon JM. Venous occlusive diseases of the retina. In: Albert DM, Jakobiec FA, Robinson NL, eds. Principles and Practice of Ophthalmology. Vol 2. Philadelphia: Saunders; 1994:735.
3. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountainis Eve Study. Arch Ophthalmol 1996;114:1243-1247.
4. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-141.
5. Cugate S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains eye study. Arch Ophthalmol 2006;124:726-732.
6. Seitz R; Blodi FC, trans. The pathologic vascular crossing ("crossing phenomena"). In: The Retinal Vessels; Comparative Ophthalmoscopic and Histologic Studies on Healthy and Diseased Eyes. St Louis, MO: Mosby; 1964:29-74.
7. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55.
8. Gass JDM. Retinal venous obstructive diseases. In: Stereoscopic Atlas of Macular Diseases. Vol 1. St Louis, MO: Mosby; 1997:546-563.
9. Weinberg D, Dodwell DG, Fern SA. Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol 1990;109:298-302.
10. Hayreh SS, Hayreh MS. Hemi-central retinal vein occulsion. Pathogenesis, clinical features, and natural history. Arch Ophthalmol 1980;98:1600-1609.
11. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77.
12. Gómez-Ulla de Irazazabal FJ, Cadarso Suarez L, Orduña Domingo E. Hemispheric retinal branch vein occlusions. Ophthalmologica 1986;193:14-22.
13. Sanborn GE, Magargal LE. Characteristics of the hemispheric retinal vein occlusion. Ophthalmology 1984;91:1616-1626.
14. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442.
15. Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 2005;40:352-368.
16. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
17. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
18. Arnarsson A, Stefansson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 2000;41:877-879.
19. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006;244:309-315.
20. Yamamoto T, Kamei M, Yokoi N, Yasuhara T, Tei M, Kinoshita S. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophthalmol 2004;138:809-817.
21. Houtsmuller AJ, Vermeulen JA, Klompe M, et al. The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl 1984;15:219-229.
22. Wiek J, Schade M, Wiederholt M, Arntz HR, Hansen LL. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution. Br J Ophthalmol 1990;74:665-669.
23. Glacet-Bernard A, Zourdani A, Milhoub M. Maraqua N, Coscas G, Soubrane G. Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:909-914.
24. Chen HC, Wiek J, Gupta A, Luckie A, Kohner EM. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998;82:162-167.
25. Dugmore WN, Raichand M. Intravitreal urokinase in the treatment of vitreous hemorrhage. Am J Ophthalmol 1973;75:779-781.
26. Daily MJ, Peyman GA, Fishman G. Intravitreal injection of methicillin for treatment of endophthalmitis. Am J Ophthalmol 1973;76:343-350.
27. Axelrod AJ, Peyman GA. Intravitreal amphotericin B treatment of experimental fungal endophthalmitis. Am J Ophthalmol 1973;76:584-588.
28. Axelrod AJ, Peyman GA, Apple DJ. Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol 1973;76:578-583.
29. Lee J, Freeman WR, Azen SP, Chung EJ, Koh HJ. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results. Retina 2007;27:1205-1213.
30. Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2006;113:800-804.
31. Sivaprasad S, McCluskey P, Lightman S. Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand 2006;84:722-733.
32. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:782-783.
33. Degenring RF, Kamppeter B, Kreissig I, Jonas JB. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand 2003;81:399-401.
34. Chen SD, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004;88:154-155.
35. Yepremyan M, Wertz FD, Tivnan T, Eversman L, Marx JL. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2005;36:30-36.
36. Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005;139:972-982.
37. Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 2005;19:65-71.
38. Cekiç O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005;25:851-855.
39. Cekiç O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina 2005;25:846-850.
40. Jonas JB, Schlichtenbrede F. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases. Eye 2008;22:869-873.
41. Ozkiris A, Evereklioglu C, Erkilic K, Dogan H. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion. Eye 2007;20:13-17.
42. Karacorlu M, Ozdemir H, Karacorlu SA. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion. Retina 2005;25:856-860.
43. Lee H, Shah GK. Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina 2005;25:551-555.
44. Patel PJ, Zaheer I, Karia N. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Eye 2008;22:60-64.
45. Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Acta Ophthalmol Scand 2005;83:600-604.
46. Prasad AG, Shah GK. Intravitreal triamcinolone for ischemic branch retinal vein occlusion with serous retinal detachment. Retina 2006;26:234-236.
47. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-221; discussion 222-223.
48. Murakami T, Takagi H, Kita M, et al. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2006;142:318-320.
49. Murakami T, Tsujikawa A, Ohta M, et al. Photoreceptor status after resolved macular edema in branch retinal vein occlusion treated with tissue plasminogen activator. Am J Ophthalmol 2007;143:171-173.
50. Blankenship GW, Okun E. Retinal tributary vein occlusion: history and management by photocoagulation. Arch Ophthalmol 1973;89:363-368.
51. Campbell CF, Wise GN. Photocoagulation therapy of branch vein obstructions. Am J Ophthalmol 1973;75:28-31.
52. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-282.
53. Shilling JS, Jones CA. Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 1984;68:196-198.
54. Parodi MB, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1999;237:1024-1027.
55. Parodi MB, Spasse S, Iacono P, Di Stefano G, Canziani T, Ravalico G. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 2006;113:2237-2242.
56. Giuffre G, Palumbo C, Randazzo-Papa G. Optociliary veins and central retinal vein occlusion. Br J Ophthalmol 1993;77:774-777.
57. McAllister IL, Yu DY, Vijayasekaran S, Barry C, Constable I. Induced chorioretinal venous anastomosis in experimental retinal branch vein occlusion. Br J Ophthalmol 1992;76:615-620.
58. McAllister IL, Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol 1995;113:456-462.
59. Browning DJ, Antoszyk AN. Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Ophthalmology 1998;105:670-677.
60. McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998;126:219-229.
61. Fekrat S, Goldberg MF, Finkelstein D. Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 1998;116:43-52.
62. Bavbek T, Yenice O, Toygar O. Problems with attempted chorioretinal venous anastomosis by laser for nonischemic CRVO and BRVO. Ophthalmologica 2005;219:267-271.
63. Quiroz-Mercado H, Sánchez-Buenfil E, Guerrero-Naranjo JL, et al. Successful erbium: YAG laser-induced chorioretinal venous anastomosis for the management of ischemic central retinal vein occlusion. A report of two cases. Graefes Arch Clin Exp Ophthalmol 2001;239:872-875.
64. Eccarius SG, Moran MJ, Slingsby JG. Choroidal neovascular membrane after laser-induced chorioretinal anastomosis. Am J Ophthalmol 1996;122:590-591.
65. Browning DJ, Rotberg MH. Vitreous Hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion. Am J Ophthalmol 1996;122:588-589.
66. Aktan SG, Subaşi M, Akbatur H, Or M. Problems of chorioretinal venous anastomosis by laser for treatment of nonischemic central retinal vein occlusion. Ophthalmologica 1998;212:389-393.
67. Lu N, Wang NL, Li ZH, Wang GL, Zhang F, Peng XY. Laser-induced chorioretinal venous anastomosis using combined lasers with different wavelengths. Eye 2007;21:962-967.
68. Leonard BC, Coupland SG, Kertes PJ, Bate R. Long-term follow-up of a modified technique for laser-induced chorioretinal venous anastomosis in nonischemic central retinal vein occlusion. Ophthalmology 2003;110:948-954.
69. Chang MA, Finkelstein D. Modified laser-induced chorioretinal anastomosis for treatment of longstanding perfused central retinal vein occlusion. Retina 2006;26:824-825.
70. Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 1988;106:1469-1471.
71. Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999;19:1-5.
72. Shah GK, Sharma S, Fineman MS, Federman J, Brown MM, Brown GC. Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2000;129:104-106.
73. Shah GK. Adventitial sheathotomy for treatment of macular edema associated with branch retinal vein occlusion. Curr Opin Ophthalmol 2000;11:171-174.
74. Le Rouic JF, Bejjani RA, Rumen F, et al. Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:747-751.
75. Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002;22:740-746.
76. Cahill MT, Kaiser PK, Sears JE, Fekrat S. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003;87:1329-1332.
77. Han DP, Bennett SR, Williams DF, Dev S. Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion. Retina 2003;23:145-151.
78. Lakhanpal RR, Javaheri M, Ruiz-Garcia H, de Juan E, Hamayun M. Transvitreal limited arteriovenous-crossing manipulation without vitrectomy for complicated branch retinal vein occlusion using 25-gauge instrumentation. Retina 2005;25:272-280.
79. Fujii GY, de Juan E Jr, Humayun MS. Improvements after sheathotomy for branch retinal vein occlusion documented by optical coherence tomography and scanning laser ophthalmoscope. Ophthalmic Surg Lasers Imaging 2003;34:49-52.
80. Mason J III, Feist R, White M Jr, Swanner J, McGwin G Jr, Emond T. Sheathotomy to decompress branch retinal vein occlusion: a matched control study. Ophthalmology 2004;111:540-545.
81. García-Arumí J, Martinez-Castillo V, Boixadera A, Blasco H, Corcostegui B. Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 2004;24:530-540.
82. Charbonnel J, Glacet-Bernard A, Korobelnik JF, et al. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy: the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 2004;242:223-228.
83. Sohn JH, Song SJ. Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusion. Korean J Ophthalmol 2006;20:210-214.
84. Feltgen N, Herrmann J, Agostini H, Sammain A, Hansen LL. Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective study. Graefes Arch Clin Exp Ophthalmol 2006;244:829-835.
85. Crafoord S, Karlsson N, la Cour M. Sheathotomy in complicated cases of branch retinal vein occlusion. Acta Ophthalmol 2008;86:146-150.
86. Yamaji H, Shiraga F, Tsuchida Y, Yamamoto Y, Ohtsuki H. Evaluation of arteriovenous crossing sheathotomy for branch retinal vein occlusion by fluorescein videoangiography and image analysis. Am J Ophthalmol 2004;137:834-841.
87. Kube T, Feltgen N, Pache M, Herrmann J, Hansen LL. Angiographic findings in arteriovenous dissection (sheathotomy) for decompressionof branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2005;243:334-338.
88. Horio N, Horiguchi M. Effect of arteriovenous sheathotomy on retinal blood flow and macular edema in patients with branch retinal vein occlusion. Am J Ophthalmol 2005;139:739-740.
89. Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology 1988;95:1335-1339.
90. Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 1999;97:465-469.
91. Saika S, Tanaka T, Miyamoto T, Ohnishi Y. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 2001;239:729-732.
92. Yamamoto S, Saito W, Yagi F, Takeuchi S, Sato E, Mizunoya S. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2004;138:907-914.
93. Chalam KV, Shah GY, Shah VA. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Comment on: Am J Ophthalmol 2004 Dec;138:907-914. Am J Ophthalmol 2005;139:1146; author reply 1146-1147.
94. Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 2007;27:49-54.
95. Mandelcorn MS, Mandelcorn E, Guan K, Adatia FA. Surgical macular decompression for macular edema in retinal vein occlusion. Can J Ophthalmol 2007;42:116-122.
96. Kumagai K, Furukawa M, Ogino N, Larson E, Uemura A. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion. Retina 2007;27:584-588.
97. Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities "hand motion" and "counting fingers" can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 2006;47:1236-1240.
98. Kirkman TW. (1996) Statistics to use. http://www.physics.csbsju.edu/ stats/. Accessed December 25, 2007.
99. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina 2004;24:676-698.
100. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3-19.
101. Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007;143:601-606.
102. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-425.
103. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006;26:352-354.
104. The Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol 1986;104:34-41.